# Shanghai Hile Bio-Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-hile-bio-technology-co

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Website: www.hile-bio.com
- Total disclosed funding: $30M
- Latest round: Series A (May 12, 2012)
- Investors on record: 3

## About

Established in 1981 and based in Shanghai, China, Shanghai Hile Bio-Technology Co., Ltd is a veterinary biologics manufacturing company. The company has 25 registered trademarks, 3 invention patents, and 42 utility model patents. The company has partnerships with the Chinese Academy of Sciences, the Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, the Beijing Academy of Agricultural and Forestry Sciences, the Nanjing Agricultural University, and the Henan Agricultural University. In May 2015, it listed on the IPO.

The company’s main business is the research and development, production, sales, and service of veterinary biological products. The company’s self-developed products include a comprehensive range of veterinary vaccines and biological products for both poultry and livestock. Its products are used in the fields of animal health and disease prevention.

The company generates revenue through the provision of veterinary biological products and services, including the sale of various vaccines and biological product lines for livestock and poultry.

## Funding rounds

- Series A, May 12, 2012, $30M — Vivo Capital, Eight Roads Ventures, New Horizon Capital

## Investors

- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series A
- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Series A
- New Horizon Capital — Series A